Dying Well with Reduced Agency:A Scoping Review and Thematic Synthesis of the decision-making process in dementia, traumatic brain injury and frailty by Birchley, Giles et al.
                          Birchley, G., Jones, K., Huxtable, R., Dixon, J., Kitzinger, J., & Clare, L.
(2016). Dying Well with Reduced Agency: A Scoping Review and Thematic
Synthesis of the decision-making process in dementia, traumatic brain injury
and frailty. BMC Medical Ethics, 17, [46]. DOI: 10.1186/s12910-016-0129-x
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1186/s12910-016-0129-x
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via BioMed Central at
http://dx.doi.org/10.1186/s12910-016-0129-x. Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
RESEARCH ARTICLE Open Access
Dying well with reduced agency: a scoping
review and thematic synthesis of the
decision-making process in dementia,
traumatic brain injury and frailty
Giles Birchley1* , Kerry Jones2, Richard Huxtable1, Jeremy Dixon3, Jenny Kitzinger4 and Linda Clare5
Abstract
Background: In most Anglophone nations, policy and law increasingly foster an autonomy-based model, raising
issues for large numbers of people who fail to fit the paradigm, and indicating problems in translating practical and
theoretical understandings of ‘good death’ to policy. Three exemplar populations are frail older people, people with
dementia and people with severe traumatic brain injury. We hypothesise that these groups face some over-lapping
challenges in securing good end-of-life care linked to their limited agency. To better understand these challenges,
we conducted a scoping review and thematic synthesis.
Methods: To capture a range of literature, we followed established scoping review methods. We then used thematic
synthesis to describe the broad themes emerging from this literature.
Results: Initial searches generated 22,375 references, and screening yielded 49, highly heterogeneous, studies that met
inclusion criteria, encompassing 12 countries and a variety of settings. The thematic synthesis identified three themes:
the first concerned the processes of end-of-life decision-making, highlighting the ambiguity of the dominant shared
decision-making process, wherein decisions are determined by families or doctors, sometimes explicitly marginalising
the antecedent decisions of patients. Despite this marginalisation, however, the patient does play a role both as a
social presence and as an active agent, by whose actions the decisions of those with authority are influenced. The
second theme examined the tension between predominant notions of a good death as ‘natural’ and the drive to
medicalise death through the lens of the experiences and actions of those faced with the actuality of death. The final
theme considered the concept of antecedent end-of-life decision-making (in all its forms), its influence on policy and
decision-making, and some caveats that arise from the studies.
Conclusions: Together these three themes indicate a number of directions for future research, which are likely to be
applicable to other conditions that result in reduced agency. Above all, this review emphasises the need for new
concepts and fresh approaches to end of life decision-making that address the needs of the growing population of
frail older people, people with dementia and those with severe traumatic brain injury.
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Background
Introduction
Humans have pondered what constitutes a good death
for millennia. From Plato’s account of Socrates’ dignified
death in Phaedo to more contemporary investigations
[1–3], a range of literature considers practical and theor-
etical understandings of what constitutes a ‘good death’
and a strong palliative care movement works actively to
promote a vision of good end-of-life care. Yet the trans-
lation of this activity to policy remains problematic. In
the United Kingdom (UK) and most Anglophone na-
tions, policy and law increasingly foster an autonomy-
based model, championing a consumer-focused concep-
tion of health provision and a central axiom of western
moral philosophy. The UK government’s end of life care
strategy [4] explicitly takes this path by primarily ad-
dressing good end of life care within the paradigm of
cancer, where active, mentally competent patients with
predictable patterns of decline seek a good death by ex-
ercising choices over their treatment and care. While the
quality of every death is important, this strategy risks
marginalising the large numbers of people who fail to fit
the paradigm.
This includes three exemplar populations: frail older
people, who face problems caused by multi-morbidity
and extreme old age, people with dementia, who face a
long term decline amid a lack of understanding of the
terminal nature of their illness, and people with the most
severe traumatic brain injury, who are often relatively
young and, in the most severe cases face a lifetime of
dependency. We hypothesise that these groups face chal-
lenges in securing good end-of-life care. Where statis-
tical data is available (for traumatic brain injury it is
not), these represent rising populations [5–7], suggesting
that an examination of the problems they face is timely.1
What, then, might it mean for people in these three
groups to ‘die well’? The Dying Well with Reduced
Agency (DWRA) project seeks to answer this question
by bringing together researchers from four UK Univer-
sities with a shared interest in end-of-life decision-
making for those who have impediments to their
decision-making ability. This paper gives details of a
scoping review and thematic synthesis that searched for
common issues in end-of-life care for the three exemplar
conditions we focused upon.
Dying with reduced agency
Not wishing to limit ourselves to the legally defined no-
tions of ‘mental capacity’, we adopt the concept of ‘re-
duced agency’ to encompass the impediments facing the
frail elderly, those with dementia, and those with severe
traumatic brain injury. This captures the sense that au-
tonomy must mean not only an ability to make a deci-
sion, but also an ability to make that decision happen.
Agency is the ability of a person or thing to act and
bring about change [8]. If we shelve philosophical ques-
tions of causation and consider that people are agents
who have free will, our level of agency reflects our ability
to act and bring about change – in people, in things.
Since reduced agency reflects a reduced ability to make
a decision effective, it is distinguishable from reduced
mental capacity, which concerns the ability to make a
decision. Dying well with reduced agency puts this in-
ability into the context of the types of things people may
decide to do (or have done) in order to have a good
death. Thus, for example, people may want to die at home,
but be too frail to assert their wishes. Alternatively, they
may, while in good health, decide to make an advance care
plan that they do not want to be aggressively resuscitated
if they have an accident, but be powerless to make anyone
respect this at the critical time.
Methods
Search methodology
The literature search followed the methodology for a
scoping study proposed by Arksey and O’Malley [9]. This
specifies a search conducted with a broad research ques-
tion, with restrictive parameters set once a sense of the
entire literature is gained. The results are delimited using
inclusion and exclusion criteria similar to systematic re-
view, but also admit time limits by utilising strict deadlines
for searching and inclusion. Data is then extracted in a
format amenable to synthesis, and reporting, of findings.
Choice of methodology is defined by both the opportun-
ities and constraints faced by the research team, and
DWRA required a rapid assessment of distinct literatures
in order to gain a broad understanding of the challenges
and concepts described within them. The breadth of the
focus meant that we did not (over-)specify a distinct re-
search question, although we required a way to manage
potentially vast amounts references generated by database
searching, and wished to do so in a rigorous and transpar-
ent way. The fact that we were aiming for breadth rather
than depth of review ruled out systematic review, as well
as more novel forms that were suitable for swift assess-
ment of precisely defined topics, such as rapid review [10].
While scoping review may be amenable to in-depth study
of a specific area, Arksey and O’Malley [9] also indicate
that scoping review may be employed in a range of other
circumstances including assessing the topology a diverse
range of literature, identifying research gaps and summar-
ising research findings. These aims seemed most in keep-
ing with what we were hoping to achieve.
Data sources
The methodology informed a search protocol devised by
the second author (KJ). Database searches were guided
by the following research questions:
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 What do we know about decision making at the
end-of-life for people with extreme frailty in old age,
severe dementia and severe traumatic brain injury?
In particular;
○Where do decisions happen?
○Who makes decisions?
○ How are decisions made?
 What are the differences and similarities in decision-
making between these groups?
The following keywords were selected on the basis of
these research questions and combined with Boolean op-
erators to identify studies: End-of-life; dying; death; hos-
pital; community; home; care home; long term care;
dementia; traumatic brain injury; brain damage; vegeta-
tive state; disorder of consciousness; decision-making;
accident and emergency; hospital; admissions; death.
Keyword searches were performed of the following data-
bases: Medline; PsychINFO; CINAHL; Cochrane data-
base of systematic reviews; Assia; Ageinfo (1945–2015).
Additionally, individual electronic searches were con-
ducted on the websites of the Journal of Housing for the
Elderly, Journal of Social Work and Long Term Care and
the British Journal of General Practice.2
Inclusion criteria
Initial search results generated 22,375 references (see
Fig. 1). These included: large volumes of clinical studies
where the target groups and conditions were absent or
constituted only small numbers of participants; legal,
ethical and social scientific literature; editorials; and
opinion pieces. While these potentially included items
that were germane to the research question (for example
literature on surrogate decision-making) we needed to
reduce the literature to quantities that were manageable
in the project timescale. We therefore decided to employ
search filters to further focus the study upon empirical
studies (reasoning these gave an indication of practice)
that included a large proportion of the populations we
sought to study:
 Addressed a population among whom frail older
people, people with dementia and/or traumatic brain
injury predominated (taken to be >75 % of participants);
 Reported original data (i.e. were empirical studies,
not reviews or editorials/opinion pieces);
 Reported on decision-making related to end-of-life
care in the community, care homes or hospital;
 Were written in English.
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Fig. 1 Flow diagram. Flow diagram of literature search and screen
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While dementia and traumatic brain injury are clinic-
ally well-defined, ‘frailty’ is a rich and contested label,
and the screening process revealed that the literature
contains many observational measures (which it was not
the purpose of this search to review) that claim to detect
frailty [11–15]. We therefore focused on papers that ex-
plicitly discussed the terms or concepts of ‘frailty’, ‘end-
of-life decision-making’ and ‘older people’. Where this
strategy was insufficient, frail old-age was taken to be
aging with the capacity to make decisions but declining
physical independence in daily activities.
Data extraction
Papers were screened first by title, then by abstract. The
full text of the papers returned was examined, with those
that failed to meet the inclusion criteria being discarded.
At each stage the inclusions and exclusions were exam-
ined independently by two authors (GB and KJ). A third
reviewer (LC) made the final decision in cases where
consensus could not be reached. Papers were not quality
assessed as this does not form a part of the review
method.
The full papers of studies that met the inclusion cri-
teria and passed subsequent title and abstract reviews
were retrieved and examined independently by the first
two authors of this paper, GB and KJ. Each paper was
reviewed and data – including sample size, study
method, intervention characteristics, location, aims, re-
sults, and the agent of decision-making (e.g. the patient,
relative and or clinician) – extracted using a pro-forma
devised by KJ, and entered into a spreadsheet. In order
to inform inductive conclusions, any additional study
characteristics that appeared salient to the reviewers
were also noted.
Characteristics of reviewed studies
The 49 studies that met the inclusion criteria had differ-
ent emphases. Sixteen were studies of frail older people,
25 were studies of dementia, eight of traumatic brain in-
jury and. Most papers focused on the views, experiences,
role or opinions of one or more participants in decisions
pertinent to end-of-life care: 15 papers focused exclu-
sively on family, friends, surrogates or other family
carers; 14 focused only on clinicians; seven focused on
both families and health care practitioners (including
nurses, care assistants and doctors) or other profes-
sionals (such as social workers and care home man-
agers); and five focused only on the person who was
subject to the decision-making.
Settings of studies varied: 16 were conducted in com-
munity settings (including people’s homes, family doctor
practices and day centres); 25 were undertaken in care
homes (including nursing and group homes); 14 were
conducted in hospitals; two were surveys conducted at
international conferences. Unsurprisingly given the Eng-
lish language restriction, most studies were conducted in
English-speaking societies, culturally sympathetic to in-
dividual autonomy [16]: 17 in the United States of
America (USA); 12 in the UK; five in the Netherlands;
three in Canada; two Hong-Kong; two Belgium; and one
each in Australia, Germany, Israel, Italy, Japan and the
Republic of Ireland; two were pan-European.
Study methods also varied. Eighteen were qualitative
or mixed methods studies that relied on in-depth inter-
view data from participants; 15 were observational stud-
ies (both prospective and retrospective) based on survey
data, chart review or other forms of observational data;
nine were epidemiological and used demographic data
from large populations; five used interventions and/or
quasi-experimental methods. The remaining two studies
were case series. A summary of the studies is given in
Additional file 1.
Theme development
Since study methods and populations were heteroge-
neous, no effort was made to summarise quantitative
data across the studies. A simple description of the data
extracted was considered unlikely to inform the research
questions; therefore, to maximise the value of the data, a
process of qualitative synthesis was undertaken by the
first author. Qualitative synthesis methods can be char-
acterised by their aspiration to create a product that is
more than the sum of its parts [17]. Thematic synthesis
is a method of qualitative synthesis described by Thomas
and Harden [18] that applies the qualitative method of
thematic analysis (which itself arose from grounded the-
ory) to literature review. Thomas and Harden describe
three stages in such a synthesis. First, papers are coded
line-by-line to pick out significant content. Second,
topics within the codes are brought together under sim-
ple ‘descriptive themes’ that capture concepts common
to groups of codes. Finally, ‘analytical themes’ are devel-
oped, consisting of researchers’ impressions and under-
standings of relationships between descriptive themes.
While utilising the method described, our method of
deriving the initial codes differed (Fig. 2). With 49 pa-
pers, we had almost five times as much source material
as Thomas and Harden [18], and limited time in which
to extract it. Our solution was more explicitly iterative,
since it involved frequent return to, and iteration be-
tween, the original sources. Since we were familiar with
the papers from the process of data extraction, we used
the secondary, extracted data (including the inductive
notes which were made during the review) as initial
codes while re-reading the papers to ensure that these
codes accurately reflected the content, revising and re-
fining the codes where necessary and adding new ones
where gaps were apparent. Each paper was thus reread
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multiple times until the reviewer was content codes ex-
hibited fealty to the original source. Through this ap-
proach, two categories were developed based upon the
study characteristics. The first related to who the study
methodology focused upon for information (e.g. families,
doctors, patients) and the second upon what factor of
the end of life process the study examined (e.g. limita-
tions to treatment, decision-making processes). These
categories were grouped into analytic themes which
reflected reviewer impressions of ideas that occurred
across multiple sources, and rich descriptions written.
The descriptions were then checked against full papers
for accuracy. Coding and theme development was pri-
marily done by the first author (GB); however, at each
stage the second author (KJ) checked the themes against
the papers for accuracy, and themes were modified until
consensus was reached. One paper from the search con-
tained codes but did not exemplify the themes well
enough to be included in the results below [19]. In total
three descriptive themes arose from the literature. These
themes focus upon the processes of decision-making, lim-
iting the intensity of medical treatment, and antecedent
end-of-life decision-making. The theme development
process is illustrated in Additional files 2 and 3, with
codes and themes arising from each paper given in
Additional file 2, and descriptions of codes given in
Additional file 3.
Results
Theme 1: decision-making processes
Decisions discussed in the papers concerned resuscita-
tion, hospitalisation, surgery, ventilation, feeding via
nasogastric tube or gastrostomy, and drug therapies such
as antibiotics and sedation, as well as euthanasia in juris-
dictions where this was legal. Such decision-making
could happen in advance (via documentary or verbal evi-
dence) or contemporaneously. In some cases advance
and contemporaneous decisions conflicted.
The papers identified the distinctive roles of families
and healthcare professionals in decision-making, but less
often directly considered the patients themselves. Fam-
ilies often had different perspectives from healthcare
professionals which, if unresolved, led to families ex-
pressing dissatisfaction with the dying process they
witnessed. The universal approach to resolving such dif-
ferences, as well as relieving the documented burdens
on families of making decisions for dependent relatives,
was shared decision-making, reflecting the current
ethico-legal steer [20]. However, family opinion carried
apparently different weight from one study to another,
suggesting that decision-making was not being shared in
a consistent manner. The patient’s own documented or
verbal antecedent end-of-life decisions (by which we
mean, among others, advance decisions and advance
care plans, see below) might be considered, but whether
these were followed depended on the outcome of med-
ical assessment of the patient’s ‘best interests’, as well as
the extent to which a family (if not agreeing with the
antecedent decision) could assert their own wishes. Al-
though rarely explicitly studied, close reading of many
papers suggests that patients themselves may influence
decision-making even when lacking capacity, and explicit
study of this phenomena seems to represent a gap in the
literature.
Who decides?
The papers presented clinical decision-making taking
place either triadically, with the healthcare professional,
patient and family member playing a role (e.g. [21]), or
else dyadically, with the family and the healthcare pro-
fessional making key decisions, albeit informed by their
understanding of what the patient might have wanted (e.g.
[22]). While it was rare to exclude any consideration of
the family [23], dyadic conceptions often excluded the pa-
tient’s active contemporaneous involvement for practical
reasons such as total patient incapacity [24, 25] or mortal-
ity [26]. But besides these practical reasons there was a
clear, although unwritten, implication that the primary
agents of decision-making were families and health care
professionals, rather than the patients with reduced
agency. Studies that directly involved patients with im-
paired capacity were rare [27, 28], while some implicitly
conflated the experiences of families and patients [29].
Family and health care professional perspectives
Family perspectives can be discordant with those of clin-
ical observers. Families of people with dementia were
often disturbed by the symptoms experienced or exhib-
ited by their relatives at the end of life, while clinical ob-
servers viewed them as consistent with a peaceful death
[30–32]. Jox et al. [33] found almost a quarter of rela-
tives of patients with traumatic brain injury disagreed
Literature 
screen
Data 
extraction
Initial 
coding
Develop 
themes
Check 
themes 
against full 
papers
Write 
up 
themes
Fig. 2 Thematic Synthesis. Diagrammatic representation of thematic synthesis
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with their doctor’s assessment of the patient’s level of
consciousness. Families of patients in the acute stage of
severe traumatic brain injury expected life-saving treat-
ment either to be almost fully restorative or to fail com-
pletely, but few accepted that the likely result was a
partial restoration of physical health alongside severe
mental disability, in spite of receiving such information
from clinicians [34]. Similar expectations were visible in
the families of people with dementia, a long term degen-
erative condition [27, 35] where death by a catastrophic
event (such as a cardiac arrest) was anticipated, rather
than a slow and extended decline.
In some cases, healthcare professionals shared the
family’s failure to acknowledge that dementia was a ter-
minal condition. Sampson et al. [27] notes that many
professionals in acute care were unaware that dementia
was a terminal illness, and two papers [30, 36] observed
that the death certificates of deceased patients who had
advanced dementia often failed to note this diagnosis as
a cause of death.
While doctors were in theory guided by the best inter-
ests of their patients, and empowered (in many jurisdic-
tions) to make decisions on that basis, clinicians were
aware that the variable opinions and philosophies within
the healthcare team led to inconsistencies in practice,
and this was considered to make any communication
problems with families worse [37].
Impact on families
Dening et al. [38] noted that family carers of people with
dementia felt the toll of caring and often had profound
regrets about their own situation, especially if they cared
for a parent rather than a spouse. Some studies also note
the burdensome and poorly supported environment in
which carers make decisions [33, 34, 39], both in demen-
tia and traumatic brain injury. Others highlight the feel-
ings of guilt or failure family carers of people with
dementia bear [25], especially about decisions that vio-
late relatives’ perceived wishes and the strong sense of
obligation carers may feel [35]. Relatives of people with
dementia may feel particularly unsupported: one epi-
demiological study of end-of-life shows that presence of
dementia in a dying relative is associated with family dis-
satisfaction with medical communication [40]. Attention
to family wellbeing may vary according to the setting,
with one study noting that families’ emotional needs
were more likely to be recorded in hospital and hospice
documentation than in nursing home records [41].
A sense of obligation may lead family members to
wish for more treatment for their relatives than they
would choose for themselves [42]. However, family
members of people with dementia who participated in
focus groups showed increased levels of regret if they
had requested aggressive interventions at the end-of-life
[25]. Such discordant thinking is also seen in health care
professionals’ wishes for their patients [43, 44].
Weight of family views
Where families requested treatment in contradiction of
previously agreed care plans [24, 34], many studies indi-
cated that their wishes were likely to be adhered to, even
if this was in opposition to the earlier expressed wishes
of the relative [24, 33, 38, 45] (note there was no evi-
dence that families rejection of treatment carried a simi-
lar weight). While this key role for the family was
widespread in dementia, traumatic brain injury and
frailty, one study indicated that family members were
rarely consulted [36] and others felt they had little influ-
ence on decision-making [29]. This finding presumably
reflects the broad scope of our literature search – one
study highlights regional and international differences in
medical values [43] – but there are also signs in the lit-
erature indicating that there can be dynamic differences
in the manifestation of shared decision-making from one
case to another.
Ambiguity of “shared decision-making”
It was implicit across studies of frailty [46, 47], dementia
[25, 32, 35, 48–53] and traumatic brain injury [33, 54]
that decisions were shared between doctors and families
and/or patients. Moreover, regardless of clinical setting,
doctors changing their treatment plans in response to
family intervention may indicate that decision-making is
to an extent shared [21, 24, 28, 55]. Yet this understand-
ing of equitable authority is muddied by reports that
family wishes were circumvented when they strayed
from the (previously agreed) medical plan in palliative
care settings [26] or where their view of what the patient
might want was in opposition to a clinician’s assessment
of best interests. In acute settings, while families often
readily acceded to aggressive lifesaving treatments, fam-
ilies who opposed these were overruled by the healthcare
team [34]. The concept of shared decision-making ap-
pears ambiguous, an ambiguity which is captured in the
finding from a survey of family members of patients
with traumatic brain injury that a majority of families
felt their role was simultaneously to make decisions and
to accede to decisions made by the doctor [33]. This
sense of a blurring of the boundaries between making
and agreeing to decisions is further compounded by one
case study series, again of traumatic brain injury, which
emphasises that decisions to withdraw nutrition and hy-
dration were made by doctors because of their challen-
ging nature [56].
The role of incapacitated patients in decisions
An important aspect of decision-making is the role that
legally incapacitated patients may play. This role is easily
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overlooked, first because the patient is not considered to
have capacity to make decisions, and secondly because
many patients with high levels of dependency display
overt unwillingness to engage with decision-making.
One survey indicated that many people with dementia
wished others, usually trusted family members, to make
decisions on their behalf [57]. Further, many people with
dementia and frailty in old age did not wish to discuss
end-of-life issues [21, 45] and people in the middle
stages of dementia could resist change and deny prob-
lems to their families and family doctors (General Practi-
tioners, hereafter GPs), especially if they were used to
holding an authoritative role in the family [25]; in these
cases families and GPs often put on a united front to
overcome this resistance.
While a lack of formal capacity results in routine mar-
ginalisation [28] or even exclusion from decision-making
[24, 49, 53, 58] of frail older people and people with de-
mentia, the documented resistance of people with de-
mentia and/or frailty in old age indicates an ability to
influence decisions. The difficulties of engaging in dis-
cussion with a previously authoritative parent or relative
[25] indicate that family dynamics may exert pressure on
how decisions happen. Indeed, this speaks to findings
that the identity of carers can have a measurable impact
on decision-making: an epidemiological study of deci-
sions to forego hospitalisation in advanced dementia
[59] showed a strong association between patients hav-
ing a proxy who was not a child and possessing a ‘do
not hospitalise’ order, which the researchers suggest in-
dicates that patients’ children may be less willing to limit
treatment than other relations (including spouses) or
court appointed proxies. Similarly, a survey by Rurup
et al. [31] notes that, while many family members agreed
with limitations to treatment for relatives at the end-of-
life, children and spouses agreed less often than those
with other familial relationships.
A variety of influences can be glimpsed in the litera-
ture; the fact that individuals with traumatic brain injury
survive at all, ‘against the odds’, in intensive care units
can be seen as grounds for hope by families [22, 33, 34].
This is significant given that Jox et al. [33] note that the
family’s perception of the patient’s wellbeing is more fre-
quently influential than the patient’s advance directives
or past attitudes. Clearly there is a symbolic role that
signs and symptoms of illness play in family reasoning.
Yet overt influences on decision-making that rely on the
patient’s physical and verbal behaviours are also
glimpsed in the literature. One survey of attitudes to
artificial nutrition and hydration noted that when nurs-
ing home residents with advanced dementia refused to
eat and drink, a large minority of relatives and nurses
(although fewer doctors) agreed that this refusal should
be ‘respected’ [31]; another study noted that GPs’
decisions to hospitalise frail older persons who lacked
capacity to make decisions were influenced by the pa-
tient’s verbal wishes as expressed at the time [55]. Such
observations offer a glimpse at the various ways that
people with impaired decision-making ability influence
the decisions of others, and such influence is recognised
in law in some jurisdictions,3 the paucity of sources in
this review may suggest that this is an under-researched
area in this literature.
Theme 2: limiting the intensity of medical treatment
While only one study explicitly examined the issue of a
‘good death’, many other studies took an implicit position
on a good death, viewing this as a death that was not
overly medicalised. The aetiology of illness dictates the
type of medicalisation to be avoided, and in the condi-
tions under investigation, medical omissions were often
of life-saving drugs (commonly antibiotics) and of artifi-
cial nutrition and hydration (usually pertaining to liquid
feeds that were administered via nasogastric or gastros-
tomy tube). While avoiding hospital or aggressive treat-
ment was associated with the idea of a good death,
many patients and carers expressed an active wish for
medical intervention, especially if confronted with acute
deterioration or imminent death. Thus there was a sub-
stantial paradox where not only a natural death, but also
aggressive life-saving treatments, were desired. Indeed,
misconceptions of the type of death a relative could ex-
pect may be compounded by under-recognition of the
trajectory of degenerative conditions among medical
professionals, affecting the information they communi-
cate to families.
Patterns of medicalisation
A number of studies documented the degree of medical-
isation of deaths, with one study reporting that almost 1
in 5 patients received ventilation, resuscitation or surgery
in the last 48 h of life [41]. Di Giulio et al. [36] observed
the frequent use of restraint, antibiotics and feeding by
gastric tube at hospital institutions caring for those dying
with advanced dementia, and others reported a compara-
tive reduction in these measures in nursing homes and
residential care [40]. While studies reported wide varia-
tions between hospitalisation rates from different nursing
homes [60, 61], Lamberg et al. [59] reviewed the records
of 244 nursing home residents dying with advanced de-
mentia, and noted that about 20 % had a period of hospi-
talisation in the last six months of life. Similarly, relatively
high proportions of frail older nursing home residents had
contact with out-of-hours care and ambulance services in
the month prior to their deaths [21]. When compared to
other types of long-term patients, length of hospital stay
of people with dementia and cognitive impairment were
lower [40, 61, 62]. Basic and Shanley [63] reported that
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people with dementia were less likely to die during hos-
pital admission, speculating this may be because those
who are hypermobile have frequent review by their doc-
tors and low nurse-to-patient ratios. Basic and Shanley’s
findings are tempered somewhat by the findings of a co-
hort study of dementia patients by Sampson et al. [64]
which reported that the likelihood of mortality for demen-
tia patient’s in acute hospitals was nevertheless high, and
increased as cognitive impairment or dementia worsened.
I am grateful to a peer reviewer for this information.
Appropriate medicalisation
It is noteworthy that some studies disputed the develop-
ment of a dogmatic approach to de-medicalised death.
For instance, while some studies indicate that vexatious
factors such as overwork, poor communication and po-
tential for litigation played a part in clinical decisions to
hospitalise nursing home patients [24], other authors
argue that some clinical emergencies, such as electrolyte
imbalances and fractures, would be inappropriate to
keep out of hospital [55], and similar themes were
highlighted by relatives of older home hospice patients
who requested hospital in the final days of life [26]. Pa-
tients may not equate a de-medicalised death with a
good death; as Soskis [65] notes, patients from margina-
lised communities “are far more likely to worry that
treatment providers will give up on them too soon or
will not consider them worth saving”.
Predicting death
Given the common steer toward a death that was not
unnecessarily medicalised, a major impediment to avoid-
ing prolongation of life for its own sake is distinguishing
terminal trajectories from other life threatening emer-
gencies [21, 38, 66]. Lamberg et al. [59] note that almost
half of decisions not to hospitalise nursing home resi-
dents with dementia took place during the last 30 days
of life, while more than half of decisions to palliate ra-
ther than actively treat took place in the last 7 days of
life. The relative lateness of such planning may of course
be related to a lack of recognition that dementia is a
cause of death in its own right, highlighted in the previ-
ous theme. Such a conclusion is in broad agreement
with a finding that GPs more frequently recognise when
deaths from cancer were about to take place than deaths
from all other conditions [46]. These authors note that
where death is not anticipated, sudden deterioration is
more likely to result in hospitalisation rather than pallia-
tive care.
What constitutes a ‘good death’?
What does, and does not, constitute a ‘good death’ is a
major area of academic debate, and this was not directly
examined in the scoping review. As noted above, many
studies took an implicit position on the meaning of a
‘good death’ by problematising the degree to which
death is medicalised. Only one study, by Bosek et al.
[30], engaged with the literature on a good death expli-
citly, attempting to reconcile family members’ perspec-
tives on the quality of death of a recently deceased
relative with late-stage Alzheimer’s disease with the
Steinhauser et al. [67] typology of good death. Bosek
et al. [30] report that, while many families were not at
the bedside when their relative died, most felt that their
relative had died with dignity. This notwithstanding,
more than a quarter of family members felt their relative
had not experienced a good death. Impediments to a
good death included undesired symptoms and, in more
than half of cases, failure to fulfil the antecedent wishes
of the individual. Bosek et al. [30] link this to the con-
cepts of symptom control and planned death that are
central to the Steinhauser et al. [67] typology, conclud-
ing that the cognitive impairments late stage dementia
present severe challenges to achieving a good death in
Steinhauser’s terms, and calling for a more proactive ap-
proach to end of life care.
Shifting perceptions of dying well
Effective symptom control may be important, but under-
standing what constitutes a symptom requires a particular
reference point, and some studies identify the unprepared-
ness of family members for the dying process. For in-
stance, a study of nurses’ and relatives’ experiences of
continuous deep sedation of dying dementia patients
theorised that differences in the familiarity of relatives and
nurses with the dying process led to differences in their
perceptions of dying as (for instance) peaceful or agonis-
ing [32]. Several other studies had similar findings; thus
studies observed antecedent wishes expressed by the pa-
tient to avoid machines or extraordinary measures [68] or
the frequent desire for natural death among family mem-
bers [35], but noted the lack of specific information about
what such deaths would involve. Indeed, families may
offer paradoxical visions of good death; thus, while elect-
ing not to treat pneumonia and other infectious diseases
is sometimes seen as allowing a natural death, both Forbes
et al. [35] and Potkins et al. [48] note that failing to treat
such conditions was often not acceptable to members of
many families of people with dementia (although, where
dementia is severe, there may be a rise in acceptability). It
is notable that death does not always follow withholding
and withdrawing antibiotics or other treatments [34, 56].
Regardless of this, a study of home hospice patients indi-
cates that the reality of the symptoms and sequelae of the
dying process prompts some families to request hospital-
isation in the final stages of life [26]. There is also a con-
sistent tendency among both professionals and family
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members toward requesting more clinical interventions
for others than they would wish for themselves [42, 44].
Requests for medical interventions are also made by
families of patients in prolonged or permanent vegeta-
tive states [33, 34]. While often thinking their relative
has an extremely poor quality of life, many families
strongly resist withdrawal of artificial nutrition and hy-
dration [22, 33], despite this being a legally permissible
avenue to a ‘natural death’ for this condition in some ju-
risdictions. Clinicians were more likely than families to
find withdrawal of artificial nutrition and hydration ac-
ceptable [37, 43, 56].
Theme 3: antecedent end-of-life decision-making
The final theme was concerned with informing future
end-of-life treatment in advance. A bewildering range of
terms—some legal, some bespoke—for such future plan-
ning were used, and the term antecedent end-of-life
decision-making (AEDM) is used here to include all the
terms encountered. Despite evidence of international
momentum in adopting AEDM practices, there is appar-
ent reluctance among some target populations to engage
in antecedent end-of-life decision-making and still large
number of obstacles confronting those who do want to
do so, and the literature described a range of barriers pa-
tients, families and professionals encounter when trying
to act in accordance with antecedent wishes. The litera-
ture revealed that families and health care professionals
find discussing death difficult, and that documentary
forms of AEDM (see below) are often felt to have little
influence on decisions in clinical practice. Implicit in
many studies was a wide variety of attitudes to death
and dying, which may speak against a single approach to
end-of-life decision-making. Despite this, some studies
succeeded in promoting antecedent end-of-life decision-
making, and documented its benefits.
A multitude of terms
A great many terms were used to describe AEDM within
the papers. In part, this was due to the diversity of this
review, drawing on papers from 13 different countries.
In total the studies used 16 terms: advance directive,
written advance directive, advance decision, advance
care plan, documented advance care wishes, anticipatory
care plan, power of attorney, durable power of attorney,
durable power of attorney for healthcare, living will,
values history, previously expressed wishes, previously
expressed patient wishes, family physician treatment
order, resident and family wishes, and familial advanced
plan. Some of these terms are legally defined, some are
not, (or are inaccurate attempts to reference legal terms)
and the latter may be unique to the studies within which
they are used. It appears evident that there are areas of
overlap between these terms, although there are also im-
portant differences; however, exploring these differences,
or the legal frameworks of different jurisdictions, is not
the focus this paper.
The most common terms were advance directives and
advance care plan, understood (in these studies and
more generally) to represent respectively legally binding
refusals of treatment, and non-legally binding statements
of wishes and preferences. The UK uses the term ad-
vance decision, rather than advance directive, which is
preferred in the USA (and refers to a broader range of
advance planning instruments). To avoid ambiguity, we
use only the terms advance decision and advance care
plan in this discussion, or where both are implied, ante-
cedent end-of-life decision-making.4
The abundance of different terminology used in the
literature may give rise to confusion among health care
professionals, and one UK study indicated that profes-
sionals were unsure of the difference between an ad-
vance decision (the legally binding refusal of treatment)
and the more generic ‘advance care plan’ [45].
Support for antecedent end-of-life decision-making
When the period preceding death is characterised by a
loss of capacity, carers and clinicians face ethical di-
lemmas about the types of treatment they should insti-
gate or withhold. The papers reviewed are unanimous in
considering end-of-life care based upon the patient’s
antecedent wishes to be the gold standard in end-of-life
treatment. While this is in line with the mores of west-
ern medicine, this review indicates that this is increas-
ingly an international viewpoint, which is reflected in
research produced in countries with little social history
of such interventions [47, 69] - albeit these studies take
place in Hong-Kong which is likely to be more suscep-
tible to the influence of British practice than mainland
China.
Barriers to antecedent end-of-life decision-making
Antecedent end-of life decision-making is a potential so-
lution to the ethical dilemmas faced by clinicians and
carers, yet this method of decision-making has failed to
permeate practice. In the USA, where advance decisions
to refuse treatment have been legally enforceable since
the early 1990s and has received extensive publicity, in-
dications are that only a third of adults have completed
some form of antecedent decision [70]. In the UK, where
advance decisions were given legal force in 2005, al-
though with little publicity, only 5 % of people are re-
ported to have formally engaged in AEDM – with fewer
taking advantage of the legal instruments [71].
The papers in this review bear out these figures, indi-
cating that some patients do not want to engage in ante-
cedent end of life decision-making, or face obstacles to
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doing so. People with dementia [28, 45] and frail older
people [21, 47], may be reluctant to think about their
deaths and consider future end-of-life wishes. This reluc-
tance is also felt by some members of families of people
with dementia [25, 39, 68] and is echoed in the re-
sponses of some families of patients with severe brain
injury who may resist making decisions to limit medical
treatment even when injuries are catastrophic [34].
Dementia studies indicate that healthcare professionals
can find it difficult to engage in discussions about end-
of-life wishes with patients [35, 49]. While other studies
report difficulties in engaging patients with advance care
planning irrespective of primary diagnosis [21, 27, 45],
the symptoms of dementia may themselves cause prob-
lems with advance care planning. Dening et al. [28] note
that the nature of the impairments people with dementia
experience means that they are more likely to focus on
their immediate concerns rather than on the future, and
this may present an obstacle to AEDM for those in the
early stages of the disease. Reluctance to discuss end-of-
life wishes can be exacerbated by a lack of close relation-
ships between staff and families, which studies reveal
can be a particular problem in nursing homes due to
high staff turnover [35, 38].
Variations among individuals and families
Families are not always uncomfortable talking about
death and making appropriate plans [34], especially if
they have personally witnessed situations where some-
one has experienced a ‘bad’ death [25, 28]. These and
other studies demonstrate clear variations in attitudes
toward death and dying among different clinicians
[37, 58], families [48, 72] and patients [65], but few show
these variations in values as clearly as Chan and Pang
[47], whose study offers a typology of nursing home resi-
dents’ approaches to advance care planning. While hav-
ing different end-of-life preferences, residents also varied
in their decisiveness, readiness to think about their
deaths, and degree of fatalism. It is clear that strategies
could be developed to address some of these barriers,
yet the study indicates that any homogenous approach
to AEDM is likely to encounter significant numbers of
patients and/or families to whom it is personally ill-
suited.
The efficacy of advance care planning
Advance care plans (excluding advance decisions) have
an advisory, rather than determinative, effect on
decision-making and dementia studies indicated that
they are overridden in the case of strong opposition
from families [35, 49]. As noted earlier, family members’
perceptions of their relative’s wellbeing had more influ-
ence on their decisions than the relative’s oral advance
wishes and past attitudes [35, 38], and the contemporary
behaviours of incapacitated patients also influenced
decision-making. There was little faith in the utility of
advance care plans among some patients, families [28]
and clinicians [38]. Indeed, the difficulties of fitting the
precepts of advance care planning to situations that in-
volve illness trajectories other than cancer has been
questioned by dementia practitioners drawn from a var-
iety of settings [45].
Overriding advance decisions
Both dementia and frailty studies report advance deci-
sions being overridden where there had been an ante-
cedent rejection of artificial nutrition and hydration [23]
and hospitalisation [59, 61].5 A survey by Rurup et al.
[31] found that many more relatives and nurses than
doctors felt that advance decisions should always be
respected; despite this, relatives’ satisfaction with end-of-
life care was more heavily influenced by a positive, trust-
ing relationship with the treating clinician than compli-
ance with the relative’s prior wishes [26].
Even where they are respected, both advance decisions
and advance care plans vary greatly in determinative
quality and content. While some studies indicate moder-
ate agreement between surrogate reports and docu-
mented patient wishes, the instructions may be non-
specific, fail to address common end-of-life dilemmas
(e.g. tube feeding and hospitalisation), or contain contra-
dictory wishes or illegal requests (e.g. for euthanasia in
the U.K.) [25, 50, 57, 65, 68].
Promoting advance care plans and advance decisions
A number of the included intervention studies were car-
ried out within care settings for older people with de-
mentia or frailty. Interventions such as staff or family
education and facilitation encouraged families and pa-
tients to document antecedent end-of-life decisions
[27, 39, 47, 52, 65, 66]. Many of these studies suggest
that benefits arise from antecedent end-of-life decision-
making. Frail older people who were involved in advance
care planning showed more life satisfaction, less existen-
tial distress and increased preference stability [47], while
GPs reported reductions in care costs and hospital ad-
missions [66]. Interventions caused bereaved families of
persons with dementia to report increased satisfaction
with end-of-life care and increased numbers of docu-
mented advance care plans [39] and advance decisions
[52] in care homes. These findings notwithstanding, a
study in an acute hospital setting reported that relatives
were frequently unwilling to make advance care plans
for family members with dementia, even with expert
guidance, and concluded that relatives may be ill-suited
to the task in these circumstances [27]. Thus, this lim-
ited range of literature suggests the success of interven-
tions to promote AEDM may depend on a variety of
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factors, including the setting and the participants, and
this deserves further investigation.
Discussion
The three themes show that clear links can be made be-
tween the three groups of patients with reduced agency.
The first theme concerns the processes of end-of-life
decision-making, highlighting the ambiguity of the dom-
inant shared decision-making process, wherein decisions
are determined by families or doctors, sometimes expli-
citly marginalising the current or antecedent decisions
of patients. Despite this marginalisation, the patient
played a role both as a social presence whose past iden-
tity and present clinical signs could be influential, and as
an active agent influencing the decisions of those with
authority. The second theme examines the tension be-
tween predominant notions of a good death as ‘natural’
and the drive to medicalise death through the experi-
ences and actions of families faced with the actuality of
death, and the impulse to treat among healthcare profes-
sions. The final theme considers the concept of ante-
cedent end-of-life decision-making (in all its forms), its
influence on policy and decision-making and some ca-
veats that arise from the studies.
Shared decision-making: family consultation, the power
of doctors and the exclusion of patient agency
Not unsurprisingly, given the legal, ethical and cultural
weight afforded to families’ views, the review indicated
that the families are the default proxies in a process of
shared decision-making. However, the importance given
to families’ opinions, rather than doctors’ opinions, var-
ied among the studies. Whatever the relative influence
of these parties, reports of advance care plans being
overridden by families or advance decisions being over-
ruled by doctors indicate the marginalisation of the
wishes of the patients themselves. This also highlights
the ambiguous nature of the concept of ‘shared’
decision-making, given that any weighting of opinions
short of complete exclusion could be argued to involve
sharing. Indeed, given the power of doctors to make de-
cisions in the best interests of their patients, shared
decision-making appeared sometimes to reduce friction
with, and lessen the burden on, families, rather than of-
fering them a determinative role in decision-making.
The ambiguity of shared decision-making has been ex-
amined at length in the literature [20, 73, 74], and the
contest between families and clinical staff over what is
best for patients is familiar [75]. Yet this description
hides a much more complex situation, glimpsed, but not
directly examined, by the studies. The way agency is
exerted—sometimes subversively—by older people who
are deemed to lack the ability to formally make decisions
has been noted by anthropologists, who document the
rebellion against resented authority that manifests in
soiling or refusing food [76]. Such a lens seems absent
from the literature reviewed, but suggests that mentally
incapacitated patients might more realistically be viewed
as participants in the decision-making process, exerting
influence in a multitude of ways. Such influences may
have biographical roots – such as the difficulty in man-
aging a previously authoritative parent – but also seem
to illustrate how cues in behaviours (such as patients re-
fusing food) or verbal wishes (demanding hospitalisa-
tion) play an active role in others’ decisions even where
the patient is not considered to be of ‘sound’ mind. In
the UK the law does go some way to acknowledging this
influence, but its weight is not settled [77]. While seek-
ing information from families is clearly necessary in
many cases (including to ascertain applicable past wishes
of patients who lack written statements), the views of
proxies should be balanced with the past and – import-
antly – the present voices of incapacitated patients. Pa-
tient agency in end-of-life decision making should
therefore form a focus of future inquiry.
‘The good death’ in theory and practice
Limiting the intensity of medical treatment was a major
focus of studies and underlined the implicit position that
a ‘good death’ is one that minimises medical intervention
and maximises choice. Maximisation of choice seems to
agree with broader perspectives on good death elsewhere
in the literature, and also reflects a policy focus that has
so far focused on death primarily in the context of can-
cer [4]. Yet there are questions about the relevance of
these concepts to longer-term degenerative illness,
where formal decision-making ability may decline or be
lost all together.
Minimising medicalisation should also not be seen as
a given: a number of studies underlined the fact that a
death without medical intervention may not always be
seen by patients (in advance care plans) or families (in
studies of satisfaction) as a good death. The actual cir-
cumstances of death, where the differences between
what is expected and what is possible markedly diverge,
may cause families to reassess prior plans, and to disre-
gard prior decisions agreed with the patient. These gaps
between expectation and reality may be driven by poor
understanding of how death happens, suggesting a need
not simply or solely to furnish families with less sani-
tised understandings of dying, but also to remedy appar-
ent failings of professional perceptions of death from
degenerative conditions. Given the failings of current
policy, correcting multiple layers of public, professional
and policy-maker misunderstanding represents a major
challenge, albeit one which future work could usefully
seek to address.
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Antecedent end-of-life decision-making: one size fits all?
While the multitude of terms used in English language
studies of antecedent decision-making might cause con-
fusion among healthcare professionals, the increasingly
international nature of antecedent end-of-life decision
making is evidenced in this review, is perhaps most not-
able when considered beside the difficulties faced in
engaging the public with antecedent end-of life decision-
making in jurisdictions where it is well-established.
While it remains difficult to engage some families and
patients, some studies have managed to overcome this
reluctance and promote more widespread AEDM (al-
though this experience is not universal). However, once
such a decision is in place, it is apparent from other
studies that it may not be respected – indeed, advisory
instruments like advance care plans seem to be readily
overridden in a process that speaks of the marginalisa-
tion of incapacitated patients, as discussed above. Be-
sides these difficulties, the existence of a variety of
different personal attitudes to decision-making suggests
that a homogenous process offering only a binary in/out
approach to AEDM may exclude large sections of the
public.
Difficulties in communicating about death speak to
the observation that dying is little understood, but even
where death is accurately anticipated there were some-
times differences between current and prior wishes, and
the effects of these temporal elements of decision-
making seem to be unexamined in the literature pertain-
ing to this theme. There may be important qualitative
reasons why antecedent and contemporary decisions are
denied equivalence that may be germane to questions
about why many people are (apparently) unmoved by
antecedent decision-making in this context. This, too,
could be a fruitful area for future inquiry.
Limitations
This study concentrated on scope rather than depth, and
moreover explicitly imposed time constraints within the
search methodology; thus it is more than likely that im-
portant studies have been overlooked and conclusions
are highly provisional. Derivation of themes is a subject-
ive process, even with such themes being checked by a
second reviewer, and it is possible that others would
offer different readings of key data. Moreover, the re-
search question that guided the literature search, in
seeking both differences and similarities between settings
and groups may have been better answered by analytic
techniques that accentuate difference and similarity.
Thematic analysis is most potent in producing a broad
sketch of multiple sources and may have therefore have
under addressed the differences and similarities sought
in the original research question. Nevertheless, given the
novelty of our focus and the fact that many findings have
arisen that are worthy of further research (which could
include a more focused review), we believe that the aims
of the review expressed at the outset of this paper have
been met.
Conclusions
This paper documents a scoping review and subsequent
qualitative synthesis that finds common features in end-
of-life care for a set of conditions that result in ‘reduced
agency’. Three major themes arose from the review:
First, the process of end-of-life decision-making took
place in the context of the rhetoric of shared decision-
making that included families and clinicians, but not,
directly, the patients themselves. Patient wishes were
sometimes overruled by doctors or families, which raises
concerns about the fragility of the patient’s autonomy
within this process. Nevertheless, patients lacking cap-
acity influenced the decisions of others through a variety
of passive and active means, and this dynamic is little
studied in the papers reviewed here. Secondly, academic,
public and professional discourse that presumed equiva-
lence between minimal medical intervention in the dying
process and a ‘good death’ vied with counterfactual re-
quests and behaviours when faced with death in reality.
Poor understanding of death may drive this paradox, not
just among the public, but among policy makers and
healthcare professionals, suggesting that corrective inter-
vention to increase understanding is a major challenge. Fi-
nally, we noted the tension between the increasingly
international adoption of antecedent end-of-life decision-
making and the difficulties in progressing this approach in
countries where it is well established. While containing
some interventions to promote antecedent end-of-life
decision-making, the studies also documented widespread
barriers to their use. Not least of these was the variety of
personal perspectives on death, which suggests that paral-
lel approaches require development.
Together these three themes indicate a number of
directions for future research in this area, which are
likely to be broadly applicable to other conditions that
result in reduced agency. Above all, this review empha-
sises the limits of current concepts and approaches to
end-of-life decision-making, and the need for fresh
approaches.
Endnotes
1Other groups such as premature babies and people
with learning disabilities are not considered here, as our
focus is on adults who had legal capacity to make their
own decisions, and have now lost it, or have severely re-
duced agency.
2Individual searches were performed on these journals
because we suspected they would publish papers par-
ticularly germane to our research question that a broad
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database search might overlook. Four papers, all from
the British Journal of General Practice were included in
the final review as a result.
3Such an influence is recognised in UK statute and
common law, although the degree of influence remains
ambiguous e.g. Re S and S (Protected Persons) Cases
11475121 and 11475138 (COP) [2008]. We have not sur-
veyed the legal position in other jurisdictions.
4Additionally, UK law also includes the Lasting Power
of Attorney for Health and Welfare where a person
names a third party to make decisions about their health
and welfare, including decisions to refuse treatment. In
this review papers considered advance care planning and
advance decisions, so this category of third party decision-
making is not explicitly considered here.
5These studies are of settings in the USA. For an
outline of the US position on Advance Decisions see
Rich [78].
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